Breaking News Bar

Business News and Information

Cancer-fighting biotech takes step closer to being Bay Area’s third IPO of the year

The South San Francisco cancer-focused biotech hopes to raise up to $92 million in an offering that would value the business as high as about $368 million.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear